Protalix BioTherapeutics CEO Moshe Manor's 2018 pay falls 23% to $718K
Protalix BioTherapeutics reports 2018 executive compensation
By ExecPay News
Published: April 12, 2019
Protalix BioTherapeutics reported fiscal year 2018 executive compensation information on April 12, 2019.
In 2018, five executives at Protalix BioTherapeutics received on average a compensation package of $510K, a 18% decrease compared to previous year.
Average pay of disclosed executives at Protalix BioTherapeutics
Moshe Manor, Chief Executive Officer, received $718K in total, which decreased by 23% compared to 2017. 50% of Manor's compensation, or $357K, was in salary. Manor also received $150K in bonus, $107K in option awards, as well as $104K in other compensation.
For fiscal year 2018, the median employee pay was $47,782 at Protalix BioTherapeutics. Therefore, the ratio of Moshe Manor's pay to the median employee pay was 15 to one.
Yossi Maimon, Chief Financial Officer, received a compensation package of $558K, which decreased by 27% compared to previous year. 51% of the compensation package, or $283K, was in salary.
Einat Brill Almon, Senior Vice President, Product Development, earned $504K in 2018, a 3% decrease compared to previous year.
Yoseph Shaaltiel, Executive Vice President, Research and Development, received $433K in 2018, which decreases by 8% compared to 2017.
Yaron Naos, Senior Vice President, Operations, earned $339K in 2018.
Related executives
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Chief Development Officer
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
Yaron Naos
Protalix BioTherapeutics
Senior Vice President, Operations
You may also like
Source: SEC filing on April 12, 2019.